GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,299,000 | +6.0% | 32,228 | +2.8% | 1.07% | +7.0% |
| Q1 2018 | $1,225,000 | +24.4% | 31,343 | +12.9% | 1.00% | +29.4% |
| Q4 2017 | $985,000 | -21.8% | 27,772 | -10.5% | 0.77% | -27.5% |
| Q3 2017 | $1,260,000 | -48.5% | 31,029 | -45.3% | 1.06% | -50.9% |
| Q2 2017 | $2,445,000 | -1.4% | 56,702 | -3.6% | 2.17% | -3.5% |
| Q1 2017 | $2,480,000 | +63.3% | 58,822 | +49.1% | 2.25% | +49.0% |
| Q4 2016 | $1,519,000 | -36.0% | 39,451 | -28.4% | 1.51% | -33.9% |
| Q3 2016 | $2,375,000 | -8.4% | 55,063 | -8.0% | 2.28% | -7.3% |
| Q2 2016 | $2,593,000 | +5.2% | 59,828 | -1.6% | 2.46% | -1.7% |
| Q1 2016 | $2,466,000 | +1.9% | 60,811 | +1.3% | 2.51% | +2.3% |
| Q4 2015 | $2,421,000 | +28.5% | 60,008 | +22.5% | 2.45% | +38.7% |
| Q3 2015 | $1,884,000 | +7.9% | 48,988 | +16.9% | 1.77% | +19.7% |
| Q2 2015 | $1,746,000 | – | 41,921 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |